General

Cell therapy may slow kidney damage from type 2 diabetes

University of Galway, in collaboration with the EU Horizon 2020-funded NEPHSTROM Consortium, has announced promising results from a new cell therapy

By Danielle Norton December 20, 2022 Updated February 20, 2024 4 min read

Photo Martina Regan.

Clinical trial shows positive results for patients across three European countries

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Comments are open to registered members. Log in or register to share your thoughts on this article.